Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peripheral Nervous System: Ganglia and Nerves01:24

Peripheral Nervous System: Ganglia and Nerves

3.5K
The Peripheral Nervous System (PNS) is a crucial component of the body's neural network, extending beyond the central nervous system (CNS) to bridge the gap between the CNS and the external environment. It encompasses nerves, ganglia, and sensory receptors.
Nerves
The nerve is a bundle of axons that serves as the communication highway in the PNS. Each nerve is ensheathed in a protective layer of connective tissue called the epineurium. This outermost layer safeguards the nerve and supports the...
3.5K
Secondary Lymphoid Organs01:15

Secondary Lymphoid Organs

7.6K
Secondary organs, including lymph nodes, the spleen, and mucosa-associated lymphoid tissue (MALT), work harmoniously to protect us from disease and infection.
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...
7.6K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

5.7K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.7K
Cranial and Spinal Meninges01:19

Cranial and Spinal Meninges

2.5K
The cranial and spinal meninges are complex protective structures surrounding the central nervous system (CNS), consisting of the brain and spinal cord. These meninges consist of the dura mater, the arachnoid mater, and the pia mater. They protect the CNS, provide structural support, and aid in circulating cerebrospinal fluid (CSF).
Cranial Meninges
These meningeal layers cover the cranium. The dura mater is the outermost layer of cranial meninges. It is a thick and durable membrane of dense...
2.5K
Nervous System01:21

Nervous System

2.8K
The nervous system coordinates body functions through its complex network of nerve cells, enabling sensation and movement. It is divided into two primary parts: the central nervous system (CNS) and the peripheral nervous system (PNS). The CNS is composed of the brain and the spinal cord. The brain acts as the body's control center, processing sensory information and coordinating responses. The spinal cord functions as a major signaling pathway for the brain and the rest of the body.
2.8K
Disorders of the Nervous Tissue01:28

Disorders of the Nervous Tissue

2.1K
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
2.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Case Report: Anti-neural cell adhesion molecule 1 antibody-positive encephalitis presenting with schizophrenia-like symptoms and an ovarian teratoma.

Frontiers in immunology·2026
Same author

Progressive Cerebral Atrophy and Cognitive Decline Without Cerebral Lesion in Neuromyelitis Optica Spectrum Disorder: A Case Report.

Cureus·2025
Same author

Clinical, Electrophysiologic, and Pathologic Features of Anti-Contactin-Associated Protein 1 Autoimmune Nodopathy.

Neurology·2025
Same author

[Paraproteinemia and Neuropathy: Medical Process to Diagnosis].

Brain and nerve = Shinkei kenkyu no shinpo·2025
Same author

[Myasthenia Gravis Treated with Zilucoplan Prior to Extended Transsternal Thymectomy for the Prevention of Myasthenic Crisis: A Case Report].

Brain and nerve = Shinkei kenkyu no shinpo·2025
Same author

Small Nuclear Ribonucleoprotein Autoantibody Associated With Blood-Nerve Barrier Breakdown in Guillain-Barré Syndrome.

Neurology(R) neuroimmunology & neuroinflammation·2025

Related Experiment Video

Updated: Nov 5, 2025

Isolating Central Nervous System Tissues and Associated Meninges for the Downstream Analysis of Immune cells
09:35

Isolating Central Nervous System Tissues and Associated Meninges for the Downstream Analysis of Immune cells

Published on: May 19, 2020

10.0K

[Sarcoidosis in Central Nervous System].

Michiaki Koga1

  • 1Department of Neurology and Clinical Neuroscience, Yamaguchi University Graduate School of Medicine.

Brain and Nerve = Shinkei Kenkyu No Shinpo
|May 19, 2021
PubMed
Summary

Neurosarcoidosis, rare but clinically significant, presents diverse neurological symptoms. While traditional treatments offer limited success, infliximab shows promise, though further evidence is needed for its efficacy in treating central nervous system sarcoidosis.

More Related Videos

Systemic and Local Drug Delivery for Treating Diseases of the Central Nervous System in Rodent Models
11:51

Systemic and Local Drug Delivery for Treating Diseases of the Central Nervous System in Rodent Models

Published on: August 16, 2010

31.0K
Isolation of Mononuclear Cells from the Central Nervous System of Rats with EAE
20:51

Isolation of Mononuclear Cells from the Central Nervous System of Rats with EAE

Published on: December 4, 2007

16.5K

Related Experiment Videos

Last Updated: Nov 5, 2025

Isolating Central Nervous System Tissues and Associated Meninges for the Downstream Analysis of Immune cells
09:35

Isolating Central Nervous System Tissues and Associated Meninges for the Downstream Analysis of Immune cells

Published on: May 19, 2020

10.0K
Systemic and Local Drug Delivery for Treating Diseases of the Central Nervous System in Rodent Models
11:51

Systemic and Local Drug Delivery for Treating Diseases of the Central Nervous System in Rodent Models

Published on: August 16, 2010

31.0K
Isolation of Mononuclear Cells from the Central Nervous System of Rats with EAE
20:51

Isolation of Mononuclear Cells from the Central Nervous System of Rats with EAE

Published on: December 4, 2007

16.5K

Area of Science:

  • Neurology
  • Immunology
  • Oncology

Background:

  • Neurosarcoidosis involves central nervous system lesions, presenting heterogeneously with varied neurological deficits.
  • It is a rare but critical differential diagnosis for unexplained neurological conditions like brain tumors, meningitis, and myelopathy.
  • Lesions in neurosarcoidosis often show resistance or partial response to standard immunotherapies, including corticosteroids and immunosuppressants, potentially causing lasting disability.

Purpose of the Study:

  • To review the clinical significance and treatment challenges of neurosarcoidosis.
  • To evaluate the potential of infliximab as a therapeutic option for neurosarcoidosis.
  • To highlight the need for high-level evidence regarding infliximab's efficacy in treating central nervous system sarcoidosis.

Main Methods:

  • Review of existing literature on neurosarcoidosis.
  • Analysis of retrospective findings on treatment outcomes.
  • Assessment of therapeutic effects of infliximab compared to standard therapies.

Main Results:

  • Neurosarcoidosis presents a diagnostic challenge due to its varied clinical manifestations.
  • Conventional immunotherapies frequently result in incomplete treatment responses and residual neurological deficits.
  • Retrospective data suggest infliximab may offer superior therapeutic effects in managing neurosarcoidosis.

Conclusions:

  • Neurosarcoidosis requires consideration in the differential diagnosis of various neurological disorders.
  • Current treatments for neurosarcoidosis have limitations, often leading to persistent neurological disability.
  • Infliximab demonstrates potential efficacy, but robust clinical trials are necessary to confirm its role in neurosarcoidosis treatment.